Cleveland Biolabs Inc (NASDAQ:CBLI)

0.3758
Data as of Nov 26
 -0.0042 / -1.11%
Today’s Change
0.33
Today|||52-Week Range
1.40
-67.88%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$21.5M

Company Description

Cleveland BioLabs, Inc. is a clinical-stage biotechnology company with a focus on oncology and acute radiation syndrome drug development. It is engaged in the research, development and commercialization of products that have the potential to treat cancer, reduce death from total body irradiation and counteract the toxic effects of radio and chemotherapies for oncology patients. The company has designed two oppositely-directed general therapeutic concepts: temporary and reversible suppression of apoptosis in normal cells to protect healthy tissues from stress-induced damage using compounds categorized as Protectans; and reactivation of apoptosis in tumor cells to eliminate cancer using compounds categorized as Curaxins. The company was founded by Andrei V. Gudkov on June 5, 2003 and is headquartered in Buffalo, NY.

Contact Information

Cleveland BioLabs, Inc.
73 High Street
Buffalo New York 14203
P:(716) 849-6810
Investor Relations:
(646) 284-9439

Employees

Shareholders

Other institutional3.62%
Mutual fund holders2.89%
Individual stakeholders11.49%

Top Executives

Yakov KoganChief Executive Officer & Director
Leah BrownleeSecretary, VP-Compliance & Operations
C. Neil LyonsCFO, Head-Investor & Public Relations
Andrei V. GudkovDirector & Chief Scientific Officer
Michael R. KurmanChief Medical Officer

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.